We contribute to society through state-of-the art non-clinical pharmacological research using our patented "STAM™ mice" technology
In order to develop new drugs, it is important to be able to accurately measure the effectiveness of drug candidates at a nonclinical trial stage.
Our "STAM™ mice" are disease model mice that more accurately reflect human pathology and therefore play a major role in pharmacology studies.
SERVICE
We support more than 600 pharmaceutical companies and bio-ventures in over 29 countries with our cutting-edge research and pharmacology studies.
SERVICE
Thanks to our extensive experience in various treatment fields, we are able to provide quick and decisive support for our client's pharmacological studies.
SERVICE
Our expert pathologists support the construction of experimental analysis systems, data acquisition and explanation of results, and maximize the information from the histology samples of pharmacology studies conducted by clients.
TRIAL
Clients are able to perform preliminary research using both blood samples and various other biospecimens from the disease model mice that SMC offer.
* AND logical operation in case of multiple words.
Model cases
ServicesNEWS RELEASE
ChemomAb’s publication on JHEP Reports.
2020.01.16
SMC announces that ChemomAb has published the results of a study using STAM™ model in JHEP Reports.
NEWS RELEASE
Advancement to clinical trials with STAM
2020.01.07
Selecting models with high clinical correlation is essential for successful drug development.
NEWS RELEASE
Column: The comparison of our STAM™ and other NASH models
2019.12.06
SMC laboratories prides itself on proprietary its NASH-HCC model ( “STAMTM mice” ) that can be used for your NASH, fibrosis and HCC R&D projects.
